يعرض 641 - 660 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( ((significant male) OR (significant all)) decrease ))', وقت الاستعلام: 0.66s تنقيح النتائج
  1. 641
  2. 642
  3. 643
  4. 644
  5. 645
  6. 646

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

    منشور في 2025
    "…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
  7. 647

    Grade system. حسب Zhuoyang Xia (21354186)

    منشور في 2025
    الموضوعات:
  8. 648

    Literature search. حسب Zhuoyang Xia (21354186)

    منشور في 2025
    الموضوعات:
  9. 649

    Study characteristics. حسب Zhuoyang Xia (21354186)

    منشور في 2025
    الموضوعات:
  10. 650

    Flowchart of literature retrieval. حسب Zhuoyang Xia (21354186)

    منشور في 2025
    الموضوعات:
  11. 651

    Data extraction. حسب Zhuoyang Xia (21354186)

    منشور في 2025
    الموضوعات:
  12. 652
  13. 653
  14. 654
  15. 655
  16. 656

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  17. 657

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  18. 658
  19. 659
  20. 660